Aurinia Pharmaceuticals Inc.
AUPH
$15.99
$0.271.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 298.21M | 287.20M | 77.84M | 60.64M | 39.85M |
| Total Depreciation and Amortization | 19.41M | 19.45M | 19.45M | 19.48M | 19.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -154.03M | -162.21M | 15.62M | 20.75M | 13.75M |
| Change in Net Operating Assets | 3.32M | -8.78M | 7.20M | -8.17M | -8.76M |
| Cash from Operations | 166.92M | 135.66M | 120.10M | 92.68M | 64.29M |
| Capital Expenditure | -274.00K | -252.00K | -461.00K | -256.00K | -286.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.61M | -32.52M | 43.67M | 46.67M | 21.35M |
| Cash from Investing | -81.88M | -32.77M | 43.21M | 46.41M | 21.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.02M | -13.14M | -12.68M | -12.19M | -11.98M |
| Issuance of Common Stock | 6.37M | 14.95M | 15.01M | 13.42M | 13.03M |
| Repurchase of Common Stock | -102.81M | -107.92M | -129.60M | -120.73M | -84.43M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -110.46M | -106.11M | -127.27M | -119.50M | -83.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.42M | -3.22M | 36.05M | 19.60M | 1.97M |